Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts
T.C.T. Hoang, D. Debieuvre, Anne-Sophie Bravard, S. Martínez et autres
BACKGROUND: The impact of the most recent advances, including targeted therapies and immune checkpoint inhibitors, on early (3-month) mortality in lung cancer is unknown. The aims of this study were to evaluate the real-world rate of and risk factors for early mortality, …
fr, lu (code pays fourni par la source)
3 citations
ESMO Open